170 NMS-E628, a potent and orally available small molecule inhibitor of anaplastic lymphoma kinase, reduces tumor growth in an intracranial model of ALK-dependent NSCLC
E. Ardini, M. Menichincheri, P. Magnaghi, C. De Ponti, N. Amboldi, A. Degrassi, M. Russo, P. Orsini, E. Pesenti, A. GalvaniVolume:
8
Année:
2010
Langue:
english
DOI:
10.1016/s1359-6349(10)71875-9
Fichier:
PDF, 46 KB
english, 2010
File converter
Plus de résultats de recherche
More benefits 
